Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure (CHF).

Milestones
edit

Viacor received $8.2M in Series B funding. (9/12/02)

Posted 11/5/09 at 12:44pm
Viacor added David Marks as CMO.

Posted 11/5/09 at 12:41pm
Viacor added Jonathan Rourke as CEO.

Posted 11/5/09 at 12:41pm
Viacor added Richard Spencer as VP Marketing, Business Development.

Posted 11/5/09 at 12:41pm
Viacor added Stanley Kyi as VP Research, Development.

Posted 11/5/09 at 12:41pm
Viacor added Christopher Hutchins as VP Engineering.

Posted 11/5/09 at 12:41pm
Viacor added William Hayes, Jr. as VP Finance, Administration.

Posted 11/5/09 at 12:41pm
Viacor added Katharine Stohlman as VP Quality Assurance, Regulatory Affairs.

Posted 11/5/09 at 12:41pm